Legalized Cannabis Market Size
According to Straits Research, The global Legalized Cannabis Market size was valued at USD 33.98 billion in 2024. It is anticipated to reach USD 253.2 billion by 2033, growing at a CAGR of 25% during the forecast period (2025-2033).
The global market encompasses the research, development, production, and marketing of drugs and medications licensed for use as therapeutic agents. These include prescription medicines, generic drugs, over-the-counter (OTC) drugs, and biologics, which play a critical role in preventing and treating diseases across the world. As healthcare systems evolve and life expectancy increases, the demand for pharmaceuticals continues to grow, driven by chronic disease prevalence, aging populations, and increasing healthcare expenditures. The scope of this report includes branded and generic pharmaceutical products across therapeutic areas such as oncology, cardiovascular, diabetes, central nervous system (CNS), infectious diseases, and rare disorders.
This report aims to provide comprehensive insights into the size, growth, and dynamics of the global market. Targeted at pharmaceutical manufacturers, investors, policymakers, regulatory bodies, and healthcare institutions, the report leverages both primary and secondary research. Primary research includes interviews with industry experts, stakeholders, and key decision-makers, while secondary research incorporates analysis from regulatory databases, industry reports, annual financial statements, and company filings. Data triangulation and bottom-up approaches have been applied to ensure accuracy.
Market Trends
Notable trends include the accelerated shift toward biologics and biosimilars, which now account for nearly 30% of global pharmaceutical revenues. Another trend is the increasing use of digital therapeutics and telemedicine, especially post-pandemic. Strategic partnerships between pharmaceutical firms and tech companies (e.g., Novartis and Microsoft’s AI collaboration) reflect a merging of disciplines. The rise of precision medicine, real-world evidence in clinical trials, and blockchain-based supply chain traceability are additional trends reshaping the industry.
Get Free Sample Report PDF @ https://straitsresearch.com/report/legalized-cannabis-market/request-sample
Legalized Cannabis Market Growth Factors
One of the primary growth drivers is the increasing global burden of chronic diseases such as cancer, cardiovascular disorders, diabetes, and respiratory ailments. For instance, according to the WHO, chronic diseases accounted for approximately 74% of global deaths in 2023, prompting a sustained demand for long-term pharmacological interventions. Another major factor is the rapid aging of populations, particularly in Europe, Japan, and North America, where people over 65 are projected to account for 25–30% of the total population by 2030. Additionally, innovations in biotechnology, such as mRNA platforms, targeted therapies, and gene editing (e.g., CRISPR), are revolutionizing drug discovery and enabling personalized treatment pathways.
Restraining Factor
Despite growth prospects, the market faces several restraints. High development costs and extended approval timelines hinder smaller companies from entering the market. The average cost to bring a new drug to market exceeds USD 2.5 billion and can take over 10 years. Regulatory hurdles, such as rigorous FDA or EMA approval processes, add to the complexity. Moreover, pricing pressures from governments and health insurers, especially in developed economies, pose profitability challenges for manufacturers. Supply chain disruptions, highlighted during the COVID-19 pandemic, further emphasize vulnerabilities in global pharmaceutical logistics.
Market Opportunity
Emerging markets like India, Brazil, Indonesia, and Sub-Saharan Africa offer substantial growth opportunities due to rising healthcare spending, increasing insurance penetration, and growing disease awareness. There is also significant potential in the development of orphan drugs for rare diseases, supported by favorable regulatory incentives in the U.S. and Europe. Technological integration, such as AI-powered drug discovery platforms and digital health monitoring, offers avenues to reduce R&D timelines and improve patient compliance.
Get Detailed Segmentation @ https://straitsresearch.com/report/legalized-cannabis-market/segmentation
Segmentation
- By Usage
- Medical
- Recreational
- Industrial Hemp
- By Form
- Bud
- Oil
- Tincture
- By Application
- Chronic Pain
- Mental Disorders
- Cancer
- Others
Competitive Landscape
- Aurora Cannabis Inc.
- Aphria Inc.
- Canopy Growth Corporation
- MedReleaf Corp
- The Cronos Group
- GW Pharmaceuticals plc
- CannTrust Ltd.
- VIVO Cannabis Inc.
- Tilray
- Organigram Holdings Inc.
- MARICANN Inc.
- Lexaria
- Bioscience Corp
- The Scotts Company LLC
- Hemp Inc.
- 22nd Century Group Inc.
Regional Insights
North America continues to dominate the global market, maintaining a leading share due to its strong research and development infrastructure, high healthcare expenditure, and robust regulatory environment. The United States contributes the vast majority of the region’s pharmaceutical revenues, reflecting its leadership in drug innovation, clinical trials, and commercial drug deployment.
Europe represents one of the largest markets globally, supported by its well-established healthcare systems and advanced medical technologies. Countries such as Germany, France, and the United Kingdom are key contributors to regional demand. While the market faces pricing and reimbursement challenges due to stringent regulatory frameworks, it benefits from policy incentives that promote research in rare and orphan diseases.
Asia Pacific is recognized as the fastest-growing regional market for pharmaceuticals, driven by economic development, expanding healthcare access, and supportive government reforms. The rise of a sizable middle-class population, aging demographics, and a strong generics manufacturing sector are key growth enablers. Strategic initiatives in countries like China and India are positioning the region as a major hub for pharmaceutical innovation and production.
The market in Latin America is undergoing steady expansion, fueled by increasing urbanization, improved healthcare access, and a growing burden of chronic diseases. Brazil and Mexico serve as major markets within the region, with evolving regulatory landscapes and expanding public healthcare programs contributing to pharmaceutical demand.
Although currently representing the smallest share among global regions, the Middle East and Africa are emerging as important markets with high growth potential. Factors such as increasing investment in healthcare infrastructure, rising prevalence of infectious and non-communicable diseases, and growing governmental focus on health system modernization particularly in Gulf Cooperation Council countries and South Africa are shaping regional development.
Top Frequently Asked Questions (FAQs)
1) What is the market size of the Legalized Cannabis Market?
2) Who are the leading players in the global market?
3) Which region is a promising market during the forecast period?
4) What are the challenges or restraints faced by the global market?
5) Which is the fastest-growing segment in the global market?
Buy Legalized Cannabis Market Research Report @ https://straitsresearch.com/buy-now/legalized-cannabis-market
About Straits Research Pvt. Ltd.
Straits Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision-making and ROI.
Whether you are looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with the client’s purchase. We overcome our clients’ issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches.
Phone: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)
Email: sales@straitsresearch.com
